TP53 and renal cell carcinoma: Increased expression of TGM2 (transglutaminase-2) in ccRCC tumors contributes to cancerous proliferation, migration and invasion [58] and enables survival of RCC cells by a mechanism involving autophagy-dependent p53 degradation [59].